2seventy bio, Inc. financial data

Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2025 - 07 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 480 % +15.3%
Debt-to-equity 123 % +8.86%
Return On Equity -1.84 % +97.7%
Return On Assets -0.83 % +97.7%
Operating Margin -138 % +58.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.3M shares +2%
Common Stock, Shares, Outstanding 52.5M shares +2.06%
Entity Public Float 198M USD -61%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 53.1M shares +1.89%
Weighted Average Number of Shares Outstanding, Diluted 53.4M shares +2.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 48.4M USD -32.1%
Research and Development Expense 38.4M USD -81.4%
Costs and Expenses 115M USD -62.6%
Operating Income (Loss) -66.8M USD +71.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.09M USD +98.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -4.09M USD +98.2%
Earnings Per Share, Basic 0 USD/shares +98.2%
Earnings Per Share, Diluted 0 USD/shares +98.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 92.4M USD +62.6%
Assets, Current 199M USD -6.7%
Property, Plant and Equipment, Net 32.3M USD -15.5%
Operating Lease, Right-of-Use Asset 200M USD -7.2%
Intangible Assets, Net (Excluding Goodwill) 5.71M USD -11%
Goodwill 0 USD -100%
Assets 480M USD -6.08%
Accounts Payable, Current 5.18M USD -41.2%
Employee-related Liabilities, Current 2.42M USD -52.5%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 41.4M USD -31.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 223M USD -7.11%
Other Liabilities, Noncurrent 1.65M USD +140%
Liabilities 266M USD -12.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 54K USD
Retained Earnings (Accumulated Deficit) -568M USD -0.73%
Stockholders' Equity Attributable to Parent 214M USD +3.14%
Liabilities and Equity 480M USD -6.08%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11M USD +73.8%
Net Cash Provided by (Used in) Financing Activities 500K USD +29.5%
Net Cash Provided by (Used in) Investing Activities 39.6M USD +81.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 52.5M shares +2.06%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 102M USD +78.9%
Deferred Tax Assets, Valuation Allowance 196M USD +8.21%
Deferred Tax Assets, Gross 257M USD +3.04%
Operating Lease, Liability 244M USD -5.05%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.7M USD +98.3%
Lessee, Operating Lease, Liability, to be Paid 313M USD -8.4%
Property, Plant and Equipment, Gross 63.8M USD -1.64%
Operating Lease, Liability, Current 16.8M USD +28.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 32.9M USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 29.5M USD +2.88%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 69.1M USD -18.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 35.1M USD +6.58%
Deferred Tax Assets, Operating Loss Carryforwards 61.7M USD +59.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.91M USD +6.22%
Lessee, Operating Lease, Liability, to be Paid, Year Four 33.1M USD -5.59%
Additional Paid in Capital 782M USD +1.33%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.64M USD -22.3%
Share-based Payment Arrangement, Expense 9.69M USD -64.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%